In vitro studies of steroid receptors in NF1
NF1 类固醇受体的体外研究
基本信息
- 批准号:7115023
- 负责人:
- 金额:$ 1.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-31 至 2006-10-31
- 项目状态:已结题
- 来源:
- 关键词:Schwann cellsandrogen receptorapoptosiscell proliferationestradiolestrogen receptorsgene expressionhormone regulation /control mechanismhormone therapyimmunocytochemistryimmunofluorescence techniqueinhibitor /antagonistligandsneoplastic growthnerve sheath neoplasmneurofibromaneurofibromatosispolymerase chain reactionprogesterone receptorsprotein localizationprotein structure functionreceptor expressionsteroid hormonesteroid hormone receptorterminal nick end labelingtissue /cell culturewestern blottings
项目摘要
Neurofibromatosis type I (NF1), a common dominant condition, is characterized by abnormal proliferation of neural crest derived cells, including Schwann cells (thought to be the clonal element) in neurofibromas. The current therapy for neurofibromas is surgery, which is usually insufficient. Neurofibromas are often aggravated during puberty and pregnancy, suggesting an altered sensitivity to steroid hormones. NF1 patients and their physicians worry about this possible correlation when faced with decisions about hormone therapies for birth control, menopause, or disease treatments. To investigate this hypothesis, the type, relative quantity and localization of hormone receptors present in NF1 tumor Schwann cell cultures compared to normal Schwann cells will be measured through RT-PCR/Western blot and immunofluorescence, respectively. To investigate the functional role of these receptors, the tumor cultures will be assayed for increased proliferation and/or survival in response to these hormones. Expression of genes believed to be downstream targets of steroid hormones will also be analyzed. These studies will characterize the role of hormones in neurofibroma development, allowing for more educated medical decisions, as well as identifying potential targets for inhibiting tumor development.
I型神经纤维瘤病(NF 1)是一种常见的显性疾病,其特征在于神经嵴衍生细胞的异常增殖,包括神经纤维瘤中的雪旺细胞(被认为是克隆成分)。目前神经纤维瘤的治疗方法是手术,这通常是不够的。神经纤维瘤通常在青春期和怀孕期间加重,表明对类固醇激素的敏感性改变。NF 1患者和他们的医生担心这种可能的相关性时,面临的决定激素治疗节育,更年期,或疾病治疗。为了研究这一假设,将分别通过RT-PCR/Western印迹和免疫荧光来测量与正常雪旺细胞相比存在于NF 1肿瘤雪旺细胞培养物中的激素受体的类型、相对量和定位。为了研究这些受体的功能作用,将测定肿瘤培养物对这些激素的应答的增殖和/或存活增加。还将分析被认为是类固醇激素下游靶点的基因的表达。这些研究将描述激素在神经纤维瘤发展中的作用,允许更多的教育医疗决策,以及确定抑制肿瘤发展的潜在靶点。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Michelle Fishbein其他文献
Lauren Michelle Fishbein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Michelle Fishbein', 18)}}的其他基金
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
遗传性副神经节瘤-嗜铬细胞瘤综合征的遗传变异和外显率
- 批准号:
10406171 - 财政年份:2020
- 资助金额:
$ 1.43万 - 项目类别:
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
遗传性副神经节瘤-嗜铬细胞瘤综合征的遗传变异和外显率
- 批准号:
10228614 - 财政年份:2020
- 资助金额:
$ 1.43万 - 项目类别:
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
遗传性副神经节瘤-嗜铬细胞瘤综合征的遗传变异和外显率
- 批准号:
10599196 - 财政年份:2020
- 资助金额:
$ 1.43万 - 项目类别:
相似海外基金
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 1.43万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10350984 - 财政年份:2022
- 资助金额:
$ 1.43万 - 项目类别:
Sensitivity of Abi1/Pten null tumors to taxane and anti-androgen receptor therapy
Abi1/Pten 无效肿瘤对紫杉烷和抗雄激素受体治疗的敏感性
- 批准号:
10430168 - 财政年份:2021
- 资助金额:
$ 1.43万 - 项目类别:
Sensitivity of Abi1/Pten null tumors to taxane and anti-androgen receptor therapy
Abi1/Pten 无效肿瘤对紫杉烷和抗雄激素受体治疗的敏感性
- 批准号:
10211354 - 财政年份:2021
- 资助金额:
$ 1.43万 - 项目类别:
Defining the role of the androgen receptor low molecular weight isoforms in bladder cancer
定义雄激素受体低分子量亚型在膀胱癌中的作用
- 批准号:
9236096 - 财政年份:2017
- 资助金额:
$ 1.43万 - 项目类别:
ARD1-dependent Androgen Receptor Signaling in Prostate Cancer
前列腺癌中 ARD1 依赖性雄激素受体信号传导
- 批准号:
8808251 - 财政年份:2015
- 资助金额:
$ 1.43万 - 项目类别:
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
ETS 因子在指定前列腺腔细胞身份和雄激素受体依赖性中的作用
- 批准号:
10570242 - 财政年份:2015
- 资助金额:
$ 1.43万 - 项目类别:
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
ETS 因子在指定前列腺腔细胞身份和雄激素受体依赖性中的作用
- 批准号:
10348178 - 财政年份:2015
- 资助金额:
$ 1.43万 - 项目类别:
Role of Androgen Receptor in Bone Metastatic Prostate Cancer Apoptosis and NED
雄激素受体在骨转移性前列腺癌细胞凋亡和 NED 中的作用
- 批准号:
8685468 - 财政年份:2014
- 资助金额:
$ 1.43万 - 项目类别:
Project 3: Exploring Ablation of the Androgen Receptor as a Therapeutic Approach for Castration-Resistant Prostate Cancer
项目 3:探索雄激素受体消融作为去势抵抗性前列腺癌的治疗方法
- 批准号:
10705234 - 财政年份:2014
- 资助金额:
$ 1.43万 - 项目类别: